Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Philippe Menu is Chief Medical Officer at Sophia Genetics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Oct 14, 2026, each linked to the official Form 4.
Chief Medical Officer
Disclosures on record
1
Companies involved
1
As of the latest filing on , Philippe Menu reported holding 195,993 shares of Sophia Genetics (SOPH), worth about $1.61M at the last close of $8 (Nov 13, 2026). In the last 12 months, Philippe Menu sold $36K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Sophia Genetics SOPH | 195,993 | 196K direct | $8 | $1.61M | Oct 12, 2026 |
Is this Philippe Menu’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Sophia GeneticsSOPH
Oct 12, 2026Sold~$36Kdisclosed Oct 14
DetailsOfficial recordPhilippe Menu has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Philippe Menu reported 0 open-market purchases and 1 sale since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $36K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 12, 2026, Philippe Menu reported holding 195,993 shares of Sophia Genetics (SOPH). At the last close of $8 on Nov 13, 2026, that is about $1.61M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Philippe Menu reported 1 open-market sale worth $36K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Philippe Menu has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Sophia Genetics (SOPH), from 2026 to 2026: 0 purchases and 1 sale.
Philippe Menu reported 0 open-market purchases and 1 sale here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
